title: Termination of transfusion dependence in beta-thalassemia: two-year experience with recombinant human erythropoietin.
authors.forename: G
authors.initials: G
authors.lastname: Nişli
authors.forename: K
authors.initials: K
authors.lastname: Kavakli
authors.forename: Y
authors.initials: Y
authors.lastname: Aydinok
authors.forename: S
authors.initials: S
authors.lastname: Oztop
authors.forename: N
authors.initials: N
authors.lastname: Cetingül
mesh_terms: D000293:Adolescent; D001803:Blood Transfusion; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000628:therapy*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin